latest health care news

14.09.20

Clinical study set to trial inhaled Covid-19 vaccines

A new clinical study, funded by UKRI and NIHR, has been launched to explore the effects of administering Covid-19 vaccines as inhaled airborne droplets rather than by injection into muscle – similar to how inhaled asthma medications are delivered.

Researchers are set to begin small trials to assess inhalation of two of the UK’s coronavirus vaccines in development, by Imperial College London and Oxford University.

These trials will assess the safety and effectiveness of delivering the vaccines directly to the respiratory tract of human volunteers, inhaled through the mouth.

It is hoped that by directly targeting the cells lining the airways, which are typical points of infection for respiratory viruses, it may be able to induce a more effective immune response. This could potentially lead to accelerating the development of effective vaccines against Covid-19 by exploring additional methods and targets.

Lead researcher Dr Chris Chiu, from the Department of Infectious Disease at Imperial College London, said: “We have evidence that delivering influenza vaccines via a nasal spray can protect people against flu, as well as help to reduce the transmission of the disease.

“We are keen to explore if this may also be the case for SARS-CoV-2 and whether delivering Covid-19 vaccines to the respiratory tract is safe and produces an effective immune response.

“The current pandemic is caused by a respiratory virus that primarily infects people through the cells lining the nose, throat and lungs.

“These surfaces are specialised and produce a different immune response to the rest of the body, so it is critical we explore whether targeting the airways directly can provide an effective response compared to a vaccine injected into muscle.”

Currently, clinical trials are being carried out to assess the safety and efficacy of numerous Covid-19 vaccines that are delivered by intramuscular injection. Dr Chiu will now work with Imperial’s Professor Robin Shattock and Oxford’s Professor Sarah Gilbert to assess the vaccines by delivering them to a small group of healthy volunteers as an aerosol.

Professor Robin Shattock, from Imperial’s Department of Infectious Disease, added: “A number of groups around the world are currently working on clinical trials for Covid-19 vaccines, and these will tell us whether these candidates can produce a systemic immune response against the virus. However, these trials are unlikely to tell us anything about the localised response in the nose, throat and airways – where the virus primarily attacks and invades cells.

“It may well be that one group has the right vaccine but the wrong delivery method, and only trials such as this will be able to tell us that. We look forward to assessing different delivery methods and pushing forward the global scientific effort against this virus.”

Comments

There are no comments. Why not be the first?

Add your comment

 

national health executive tv

more videos >

featured articles

View all News

last word

Haseeb Ahmad: ‘We all have a role to play in getting innovations quicker’

Haseeb Ahmad: ‘We all have a role to play in getting innovations quicker’

Haseeb Ahmad, president of the Association of the British Pharmaceutical Industry (ABPI), sits down with National Health Executive as part of our Last Word Q&A series. Would you talk us throu more > more last word articles >

health service focus

View all News

comment

NHS England dementia director prescribes rugby for mental health and dementia patients

23/09/2019NHS England dementia director prescribes rugby for mental health and dementia patients

Reason to celebrate as NHS says watching rugby can be good for your mental ... more >
Peter Kyle MP: It’s time to say thank you this Public Service Day

21/06/2019Peter Kyle MP: It’s time to say thank you this Public Service Day

Taking time to say thank you is one of the hidden pillars of a society. Bei... more >

interviews

Organ Donation Week: Having the conversation

11/09/2020Organ Donation Week: Having the conversation

As part of Organ Donation Week, NHE’s Matt Roberts spoke with our Man... more >

the scalpel's daily blog

NICE’s support for rebuilding capacity in non-Covid health services

18/09/2020NICE’s support for rebuilding capacity in non-Covid health services

Paul Chrisp, Director of the Centre for Guidelines, NICE When the Covid-19 pandemic hit the UK’s shores earlier this year, the NHS responded quickly, diverting and ... more >
read more blog posts from 'the scalpel' >